CGC Genetics

Portuguese genetic testing firm CGC Genetics recently launched a Diabetes/Obesity Mutation Panel that it claims can be used for preventive purposes.

CGC Genetics, a clinical genetics testing company, recently introduced a panel for skeletal dysplasias.
The assay runs on Illumina's digital microbead-based BeadXpress system, and bolsters the Porto, Portugal-based company's menu of Array CGC tests.

The Portugal-based testing company is one of a handful of firms to adopt the holographic microbead-based platform since the US Food and Drug Administration cleared the BeadXpress earlier this year.

New Product Watch

Premium

Exiqon's Mircury LNA MicroRNA Arrays, CGC Genetics' Prenatal Diagnostic Test

New Product Watch

Premium

CGC Genetics' Congenital Deafness Panel, EMD Millipore's CpGenome Turbo Kit

New Product Watch

Premium

Oxford Gene Technology's CytoSure ISCA UPD 4 x 180K Array; CGC Genetics' Microarray Panels for the Diagnosis of Bardet-Biedl Syndrome, Thrombophilia, and Warfarin Pharmacogenetics

The Portuguese genetic testing company has located its US headquarters in Newark, NJ, and it has partnered with New Jersey Medical School's Institute of Genomic Medicine.

The Portuguese lab firm received its CLIA license less than a year after being among a handful of firms to receive a warning notice from California regulators.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.